109 related articles for article (PubMed ID: 33378758)
1. Medical Care and Survival of Soft-Tissue and Bone Sarcoma Patients: Results and Methodological Aspects of a German Subnational Cohort Study Based on Administrative Healthcare Data.
Schoffer O; Roessler M; Datzmann T; Andreou D; Jakob J; Eichler M; Richter S; Schuler MK; Schmitt J
Oncol Res Treat; 2021; 44(3):103-110. PubMed ID: 33378758
[TBL] [Abstract][Full Text] [Related]
2. Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015.
Kollár A; Rothermundt C; Klenke F; Bode B; Baumhoer D; Arndt V; Feller A;
Cancer Epidemiol; 2019 Dec; 63():101596. PubMed ID: 31520938
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of (18)F-FDG PET at diagnosis in patients with soft tissue sarcoma and bone sarcoma; systematic review and meta-analysis.
Kubo T; Furuta T; Johan MP; Ochi M
Eur J Cancer; 2016 May; 58():104-11. PubMed ID: 26990930
[TBL] [Abstract][Full Text] [Related]
4. Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma.
Andersen KF; Fuglo HM; Rasmussen SH; Petersen MM; Loft A
Medicine (Baltimore); 2015 Jul; 94(28):e1142. PubMed ID: 26181552
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in soft tissue sarcoma.
Maretty-Nielsen K
Dan Med J; 2014 Nov; 61(11):B4957. PubMed ID: 25370967
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of soft tissue and bone sarcomas from benign lesions utilizing
Chen B; Feng H; Xie J; Li C; Zhang Y; Wang S
BMC Med Imaging; 2020 Jul; 20(1):85. PubMed ID: 32711449
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of Patients with Metastatic Soft Tissue Sarcoma: Advances in Recent Years.
Lochner J; Menge F; Vassos N; Hohenberger P; Kasper B
Oncol Res Treat; 2020; 43(11):613-619. PubMed ID: 32854101
[TBL] [Abstract][Full Text] [Related]
8. 'Beware the lump in the foot!': predictors of recurrence and survival in bone and soft-tissue sarcomas of the foot and ankle.
Salipas A; Dowsey MM; May D; Choong PF
ANZ J Surg; 2014; 84(7-8):533-8. PubMed ID: 24712375
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of treatment patterns among recurrent/metastatic soft tissue sarcoma patients who consulted medical oncologists in Japan.
Nakano K; Ae K; Matsumoto S; Takahashi S
J Orthop Sci; 2019 Nov; 24(6):1081-1087. PubMed ID: 31447093
[TBL] [Abstract][Full Text] [Related]
10. Regional variation in the survival of patients with a soft-tissue sarcoma of the extremity and trunk wall under a centralized care system : what has been the impact of national policies in the UK?
Fujiwara T; Evans S; Stevenson J; Tsuda Y; Gregory J; Grimer RJ; Abudu S
Bone Joint J; 2021 Sep; 103-B(9):1541-1549. PubMed ID: 34465152
[TBL] [Abstract][Full Text] [Related]
11. A population-based study of soft tissue sarcoma incidence and survival in Australia: An analysis of 26,970 cases.
Bessen T; Caughey GE; Shakib S; Potter JA; Reid J; Farshid G; Roder D; Neuhaus SJ
Cancer Epidemiol; 2019 Dec; 63():101590. PubMed ID: 31520939
[TBL] [Abstract][Full Text] [Related]
12. Soft tissue sarcoma brain metastases. Prevalence in a cohort of 3829 patients.
Espat NJ; Bilsky M; Lewis JJ; Leung D; Brennan MF
Cancer; 2002 May; 94(10):2706-11. PubMed ID: 12173340
[TBL] [Abstract][Full Text] [Related]
13. Management of Sarcoma in Adolescents and Young Adults: An Australian Population-Based Study.
White VM; Orme LM; Skaczkowski G; Pinkerton R; Coory M; Osborn M; Bibby H; Nicholls W; Conyers R; Phillips MB; Harrup R; Walker R; Thompson K; Anazodo A
J Adolesc Young Adult Oncol; 2019 Jun; 8(3):272-280. PubMed ID: 30822262
[No Abstract] [Full Text] [Related]
14. Steady survival improvements in soft tissue and bone sarcoma in the Nordic countries through 50 years.
Tichanek F; Försti A; Hemminki O; Hemminki A; Hemminki K
Cancer Epidemiol; 2023 Sep; ():102449. PubMed ID: 37679266
[TBL] [Abstract][Full Text] [Related]
15. Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity.
Vlenterie M; Litière S; Rizzo E; Marréaud S; Judson I; Gelderblom H; Le Cesne A; Wardelmann E; Messiou C; Gronchi A; van der Graaf WT
Eur J Cancer; 2016 May; 58():62-72. PubMed ID: 26968015
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of Adult Soft-Tissue Sarcomas in Germany.
Saltus CW; Calingaert B; Candrilli S; Lorenzo M; D'yachkova Y; Otto T; Wagner U; Kaye JA
Sarcoma; 2018; 2018():5671926. PubMed ID: 29849478
[TBL] [Abstract][Full Text] [Related]
17. The sarcoma diagnostic interval: a systematic review on length, contributing factors and patient outcomes.
Soomers V; Husson O; Young R; Desar I; Van der Graaf W
ESMO Open; 2020 Feb; 5(1):. PubMed ID: 32079621
[TBL] [Abstract][Full Text] [Related]
18. The impact of antecedent primary malignancy in soft tissue sarcoma patients.
Torigoe T; Imanishi J; Yazawa Y; Kadono Y; Oda H
J Orthop Surg (Hong Kong); 2019; 27(2):2309499019838124. PubMed ID: 30909802
[TBL] [Abstract][Full Text] [Related]
19. Curability of patients with lymph node metastases from extremity soft-tissue sarcoma.
Basile G; Mattei JC; Alshaygy I; Griffin AM; Catton CN; Chung PW; Shultz DB; Razak ARA; Demicco EG; Ferguson PC; Wunder JS
Cancer; 2020 Dec; 126(23):5098-5108. PubMed ID: 32910462
[TBL] [Abstract][Full Text] [Related]
20. Continuous 14 Day Infusional Ifosfamide for Management of Soft-Tissue and Bone Sarcoma: A Single Centre Retrospective Cohort Analysis.
Carter TJ; Milic M; McDerra J; McTiernan A; Ahmed M; Karavasilis V; Michelagnoli M; Windsor R; Seddon B; Whelan J; Dileo P; Strauss SJ
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33212978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
